Significantly increased expression of AKAP9 in pathologically changed thyroid tissue and in more advanced cancer stages (pT2-4, Stage II-IV) may be potentially used as a thyroid tumorigenesis marker. This evidence concerns the gene AKAP9 and thyroid gland disorder.